Physician profile
Andrew Lu
NPI 1891837779
$14,631.86
in general payments reported to CMS, 2019-2025
16 companies · $1,923 in 2025
The $1,923 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,383 · 2020: $770 · 2021: $1,263 · 2022: $1,550 · 2023: $2,600 · 2024: $4,143 · 2025: $1,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,622 · Travel and Lodging: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,622.15 |
| Travel and Lodging | $1,043.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,162.35 | 2019-2025 | Dailies Total1, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $4,125.90 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $2,476.37 | 2022-2025 | Infuse, Biotrue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $931.62 | 2019-2021 | |
| Coopervision INC. | $711.93 | 2019-2025 | Myday Contact Lens |
| Lumenis Be INC | $237.27 | 2023 | M22 |
| Sight Sciences, INC. | $147.33 | 2023 | Tearcare System |
| Abbvie INC. | $128.12 | 2023 | |
| Omeros Corporation | $125.00 | 2020 | |
| Horizon Therapeutics Plc | $122.09 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $121.84 | 2024 | |
| Dompe US, INC. | $104.67 | 2024 | Oxervate |
| Amgen INC. | $97.45 | 2024 | Tepezza |
| Optos, INC. | $88.59 | 2022 | |
| Biotissue Holdings INC. | $34.09 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.